<- Go Home
Minerva Surgical, Inc.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Market Cap
$8.00
Volume
83.0K
Cash and Equivalents
$11.1M
EBITDA
-$25.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$28.0M
Profit Margin
54.18%
52 Week High
$3.49
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
0.00
Price / Tangible Book Value
-0.00
Enterprise Value
$32.4M
Enterprise Value / EBITDA
-1.32
Operating Income
-$34.3M
Return on Equity
160.07%
Return on Assets
-27.35
Cash and Short Term Investments
$11.1M
Debt
$43.6M
Equity
$20.3M
Revenue
$51.7M
Unlevered FCF
-$16.0M
Sector
Health Care Equipment and Supplies
Category
N/A